Nune Markosyan
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Inflammatory mediators and NSAID effects 7
- Oncology 6
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Robert H. Vonderheide (6 shared papers)Diane M. Duffy (3 shared papers)Emer M. Smyth (6 shared papers)Rebecca A. Evans (2 shared papers)Ben Z. Stanger (5 shared papers)Garret A. FitzGerald (4 shared papers)Andrew J. Rech (2 shared papers)Katelyn T. Byrne (3 shared papers)
- Journals
- Carcinogenesis (2 papers)JCI Insight (2 papers)npj Breast Cancer (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Endocrinology (1 paper)
- Partner nations
- United StatesSlovakiaNorway
In The Last Decade
Nune Markosyan
13 papers receiving 500 citations
Peers
Comparison fields: 5 of 67
- Oncology 222
- Immunology 169
- Pharmacology 89
- Cancer Research 62
- Biochemistry 27
Countries citing papers authored by Nune Markosyan
This map shows the geographic impact of Nune Markosyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nune Markosyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nune Markosyan more than expected).
Fields of papers citing papers by Nune Markosyan
This network shows the impact of papers produced by Nune Markosyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nune Markosyan. The network helps show where Nune Markosyan may publish in the future.
Co-authors
The 25 scholars most cited alongside Nune Markosyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 124 | |
| 2 | 2019 | 121 | |
| 3 | 2013 | 55 | |
| 4 | 2014 | 42 | |
| 5 | 2011 | 38 | |
| 6 | 2008 | 34 | |
| 7 | 2006 | 22 | |
| 8 | 2015 | 17 | |
| 9 | 2012 | 16 | |
| 10 | 2014 | 15 | |
| 11 | 2025 | 15 | |
| 12 | 2024 | 4 | |
| 13 | 2025 | 1 | |
| 14 | 2026 | 0 | |
| 15 | 2026 | 0 |
About Nune Markosyan
Nune Markosyan is a scholar working on Pharmacology, Oncology, Genetics, Immunology and Psychiatry and Mental health, having authored 15 papers that have together received 504 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Immunotherapy and Immune Responses (2 papers), Immune cells in cancer (2 papers) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Oncology (222 citations), Immunology (169 citations), Pharmacology (89 citations), Cancer Research (62 citations) and Biochemistry (27 citations). Nune Markosyan has collaborated with scholars based in United States, Slovakia and Norway. Frequent co-authors include Robert H. Vonderheide, Diane M. Duffy, Emer M. Smyth, Rebecca A. Evans, Ben Z. Stanger, Garret A. FitzGerald, Andrew J. Rech, Katelyn T. Byrne, Mark S. Diamond and Max W. Richardson. Their work appears in journals such as Carcinogenesis, JCI Insight, npj Breast Cancer, Arteriosclerosis Thrombosis and Vascular Biology and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.